S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
BABA   182.48 (-2.40%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
BAC   32.79 (-0.91%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
BABA   182.48 (-2.40%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
BAC   32.79 (-0.91%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
BABA   182.48 (-2.40%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
BAC   32.79 (-0.91%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
BABA   182.48 (-2.40%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
BAC   32.79 (-0.91%)
Log in

AstraZeneca Price Target & Analyst Ratings (LON:AZN)

GBX 7,387
+112.00 (+1.54 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
7,255.52
Now: GBX 7,387
7,427
50-Day Range
6,729
MA: GBX 7,160.10
7,580
52-Week Range
5,312
Now: GBX 7,387
8,227.88
Volume1.09 million shs
Average Volume2.31 million shs
Market Capitalization£96.91 billion
P/E Ratio46.34
Dividend Yield2.92%
BetaN/A

Analyst Ratings

AstraZeneca (LON:AZN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
17 Wall Street analysts have issued ratings and price targets for AstraZeneca in the last 12 months. Their average twelve-month price target is GBX 7,465.67The high price target for AZN is £100 and the low price target for AZN is GBX 5,500. There are currently 3 sell ratings, 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.412.332.372.45
Ratings Breakdown: 3 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
6 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 7,465.67GBX 7,062.50GBX 6,676.47GBX 6,397.70

AstraZeneca (LON:AZN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

AstraZeneca (LON:AZN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
11/13/2019Deutsche BankReiterated RatingBuyGBX 8,300
11/11/2019UBS GroupReiterated RatingSellGBX 5,800
11/11/2019Jefferies Financial GroupReiterated RatingHoldGBX 6,700
11/11/2019Liberum CapitalReiterated RatingBuy
11/8/2019JPMorgan Chase & Co.Set Price TargetBuyGBX 7,900
11/8/2019Shore CapitalReiterated RatingBuy
11/7/2019CitigroupReiterated RatingBuy
10/30/2019Goldman Sachs GroupSet Price TargetSellGBX 5,500
10/29/2019Kepler Capital MarketsBoost Price TargetBuyGBX 7,700 ➝ GBX 8,000
10/25/2019Credit Suisse GroupSet Price TargetBuyGBX 7,300
10/17/2019HSBCSet Price TargetSellGBX 6,235
10/15/2019BarclaysReiterated RatingOverweight
10/8/2019Bank of AmericaReiterated RatingBuyGBX 8,500
9/10/2019Societe GeneraleReiterated RatingBuy
7/3/2019Bryan, Garnier & CoReiterated RatingNeutral
5/7/2019Morgan StanleyBoost Price TargetEqual WeightGBX 6,400 ➝ GBX 6,500
11/19/2018InvestecDowngradeHoldGBX 5,500 ➝ GBX 6,300
11/9/2018CfraSet Price TargetNeutralGBX 6,200
9/11/2018BNP ParibasSet Price TargetBuyGBX 6,500
6/8/2018Berenberg BankReiterated RatingBuyGBX 6,200
5/21/2018Sanford C. BernsteinUpgradeOutperformGBX 5,673 ➝ GBX 6,026
(Data available from 11/13/2017 forward)
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel